Introduction
Allergic diseases are considered to be the most common diseases in pediatrics. According to epidemiological studies, in the Republic of Uzbekistan 33-35% of the population, including pediatric, suffer allergic reactions and diseases, among which atopic dermatitis is one of the most common (25%). Because of unfavorable epidemiological situation on infectious diseases in the country, the problem on full coverage of pediatric population with preventive vaccination is urgent issue (Chebotareva, Mazankova, Gorkin, and Ivanova, 2005; Kostinov, 2006; Chernova, 2007) . Vaccination may enhance allergic reactivity in children with severe allergic anamnesis for vaccination period, but we should consider this as a natural mechanism of the immune response in this group of children. Vaccination for children with allergic diseases is currently the subject of discussion, both among healthcare professionals and the public opinion, although in recent years the number of supporters of the active immunization of this population increases (Uchaykin and Shamsheva, 2006; Magarshak and Kostinov, 2008) . Some researchers (Fedorov, Tatochenko, Vundtsettel et al., 2005; Tatochenko, 2007) not only confirm the possibility, but also indicate the need of active immunization of these children, as the risk of moderate exacerbation of the underlying disease following immunization is negligible. According to Balabolkin (2003) and Harit et al. (2007) , an individual approach is necessary and main condition for effective immunization of these patients, which is characterized by the nature of the course of allergic disease, duration of remission, and the child's age. Therefore, the experience of vaccination of children with allergic altered reactivity and study the features of the process of vaccination may be of particular interest.
Methods

Context
The problems, which we can meet during vaccination of these children, may be, first, the effectiveness, as the children are more susceptible to infections, that is epidemiologically significant for timely vaccination. On the other hand, it is the safety of vaccination, as during the administration of preventive immunizations they may develop a variety of adverse effects following immunization (AEFI). According to Zemskov et al. (2011) , this is based on the state of immunological competence of the organism in response to vaccine antigens. Taking this fact into account, the aim of this study was to investigate the immunological effectiveness and safety of vaccination in children with allergic diseases.
Subjects
64 children with allergic diseases (bronchial asthma, respiratory allergies, atopic dermatitis, allergic rhinitis) (main group) aged from 1 to 3 years old were examined in Out-Patient Department of the Republican Specialized Scientific-Practical Medical Center of Pediatrics of the Ministry of Public Health of the Republic of Uzbekistan in the period of introduction of preventive vaccination. Vaccination history of the investigated children was studied from medical documentations. Children with the similar disorder, who prior the survey received medications that could affect the defined parameters of the immune system, were excluded from the study. The control group consisted of 45 healthy children of the similar age, who were immunized with measles vaccine in one year, that is, in standard terms of preventive vaccination of the national calendar (according to the rules and regulations for the organization and conducting of immunization of infectious diseases of Uzbekistan). Participants' parents were informed with the study objectives and provided their informed consent for participation and permission of the local ethical committee to conduct the study was obtained.
Design
Blood serum samples of children were obtained for serological studies after vaccination with measles vaccine (MMR -vaccine to measles, mumps and rubella), according to the national vaccination calendar (according to the rules and regulations for the organization and conducting of immunization of infectious diseases of Uzbekistan). Whole blood samples of children were collected before MMR vaccination in order to study the immune status.
Laboratory methods
Serological studies. For studying mechanisms of immune cells respond to antigenic stimuli and the formation of specific immunity to vaccine-preventable diseases, in all surveyed children after measles vaccination serologic studies were conducted. Determining the level of measles antibodies in blood serum was carried out by direct hemagglutination reaction (DHAR) with dry diagnosticum measles. Those without antibodies to measles were believed seronegative. Protecting against measles were considered antibody titers after DHAR above 1:10; whereas measles antibody titers 1:10-1:20 were considered as low, 1:40-1:80 -average, and 1:80 and above -high level of protection. Immunological studies. Evaluation of immunological parameters was performed prior to vaccination with the determination of cellular and humoral immunity, as well as nonspecific defense factors. Determination of cellular immunity was performed using monoclonal antibodies of "Medbiospektr" (Moscow, Russian Federation) by indirect rosette formation. Immunoglobulins were determined by radial immunodiffusion by the method of Manchini (1965) using commercial antisera to immunoglobulins A, M, G and E (production of Research Institute name after Gamaleya, Russian Federation). Phagocytic activity of neutrophils (NPA) was measured in the test with latex produced by "Biologics" (Russian Federation). We used the method of specific diagnostics in vitro on dynamic expression of the level of common leukocyte antigen CD45-test (developed in 1996 by researchers of the Samara Diagnostic Center). This test is proposed and used to determine the specific hypersensitivity in examining children during vaccination (in test-system in vitro vaccines are used). In this case, the dynamics of CD45 expression is represented as a coefficient of sensitization (CS). From the view of the current data on the significance of dynamics of expression level of common leukocyte antigen CD45, in assessing the specific sensitivity to specific antigens, the use of this test in vaccinology is of particular interest. Because of structural and functional features of CD45, in the test-system in vitro to antigens CD45 can serve as indicator of the degree of sensitization to a specific antigen. Analytical studies. The data of comprehensive examination of patients were proceeded with a special computer program. For a more detailed assessment of the degree of immune disorders, we evaluated immune disorders degree (IDD) using a universal formula proposed by Zemskova (1995) and frequency analysis. If the value obtained is negative, the patient has an immune deficiency; if the value is positive, the child has hyperactive immune system. In the case when the calculated value ranges between 1-33%, this is the first degree of immunological disorders, which is a transient state and disappears independently, without immunocorrection. The value interval of 34-66% corresponds to the second degree, above 66% -the third degree, which disappear after use of immunomodulators. Additionally, we calculated coefficient of diagnostic value using the formula of Gorelik and Skripkina (1974), followed by determination of the main immunological parametersFormula of immune system disorders (FISD) by the method of Zemskov (1995) . FRIS was determined using the coefficient of diagnostic value, which allows to select the top three most informatively significant indicators of the 2nd and 3rd degree of immune deficiency, taking into account the average values of the parameters and their variances.
Results
Analysis of medical documentations
Following immunization children with allergic diseases had adverse effects, of which the true vaccine reactions were observed in 30% of children, the true vaccination complications (urticaria, angioedema) in 7.5% of patients, worsening of the underlying disease in 18% of children, developing of intercurrent diseases in 35.4% of subjects.
Post-vaccination immunity
Study of the level of antibodies to measles. Study of the rate of post-vaccination titers of measles antibodies has shown that 23.4% of children in the main group had seronegative results. The rate of children with the production of antibodies in titer 1:10 was not significantly different from the results of the control group (p>0.05) ( Table 1) . Number of children with a titer of antibodies to measles 1:20 in the group with allergic diseases was 2-fold lower (p<0.05). Geometric mean of antibody titers to measles in the main group was 1:23±0.8, that is significantly lower, in comparison with the control group (1:97±1.2). In children with allergic conditions and diseases we calculated the coefficient of diagnostic value of each parameter of immune status, on the basis of which has been developed the following formula: CD16³-CD8³-Lymph²-NPA²-CD4²-Тl²-IgE³+IgM²+Вl²-IgA²+. According to this formula, the key indicators of hypofunction of immune system by immunity links have been established the following: CD16³-СD8³-Lymph²-(Formula of immune system disorders -FISD). In surveyed children FISD was characterized by decline of CD16 and CD8 of 3rd degree, as well as decrease of lymphocyte levels of 2nd degree. Thus, survey of children with allergic diseases during vaccination process has revealed serious violations of the immune status, which were characterized by immune deficiency by cellular and NPA indicators in high percentage of examined children, as well as by hyperactivity on the levels of immunoglobulins between the 2nd and 3rd degrees. Study of expression level of common leukocyte antigen CD45 in test-system in vitro with MMR vaccine showed significant changes in children with allergic diseases, in comparison with children without these disorders (Table 3) . Thus, because of structural and functional features, CD45 to antigens in test-system in vitro can serve as indicator of the degree of sensitization to a specific antigen, in our case to the vaccine.
Discussion
Allergic diseases impair the immune status of children, inhibiting the cellular and humoral immunity factors. This fact is crucial to the further formation of the immune system, particularly in the formation of the ability to adequately respond to antigenic exposure, including vaccination. Assessment of immunity to measles in these children has revealed high frequency of low titer and seronegative results of vaccination. This means that protection against the infection was not sufficient. This category of children can create risk group for measles. The survey of vaccinated children with allergic diseases during vaccination process has found serious violations of the immune status, which were characterized by deficit or hyperactivity of T-cell system, phagocytosis and disimmunoglobulinemia. Consequently, all of this could reduce the effectiveness of immunization against vaccine-preventable diseases in this group of children during vaccination with live vaccines (MMR). On the other hand, discoordination of the immune system is one of the factors in the development of adverse effects at the period of preventive vaccination. In this regard, in children with allergic diseases use of the test of specific hypersensitivity to vaccines prior to immunization will reduce the post-vaccination reactions and complications. Therefore, the process of intervention in the immune system of children with allergic diseases to form protective immunity should be based on an individual approach. This means that immunization in these patients should be supervised by a competent, experienced immunologist and accompanied by laboratory immunoassay during the vaccination process. When deciding on the timing of vaccination, the volume of medical intervention and selecting vaccine preparation, we should consider the spectrum of sensitization, nosological form and stage of the disease, i.e. an individual approach to each child is necessary in the strategy of vaccination of children with allergic diseases.
Conclusion
According to our study, post-vaccination period after the introduction of measles vaccine in children with allergic diseases is characterized by the development of adverse effects following immunization in 90.9% of children. After immunization of children with allergic diseases to measles in the standard calendar dates of preventive immunizations, there is a high frequency of seronegative results and low antibody titers. Indicators of the immune system in children with allergic diseases at the period of preventive vaccination with MMR vaccine are characterized by high frequency of immune disorders of 2nd and 3rd degree and increased CD45 expression in test-system in vitro. Thus, children with allergic diseases may be immunized with measles vaccine. Before vaccination these children require immunological examination (determination of cellular and humoral immune system parameters), with subsequent individual justification (IDD of 2-3 degrees) of the need for immunocorrection. In case of detection sensitization of the organism to the vaccine antigen by determining the specific level of expression of common leukocyte antigen CD45 in test-system in vitro, use of not titrated live vaccines as antigens, in this case measles vaccines, is not recommended.
